Literature DB >> 15070892

Reoxygenation-induced constriction in murine coronary arteries: the role of endothelial NADPH oxidase (gp91phox) and intracellular superoxide.

John Q Liu1, Igor N Zelko, Rodney J Folz.   

Abstract

Previous work suggests that superoxide mediates hypoxia/reoxygenation (H/R)-induced constriction of isolated mouse coronary arteries (CA). To determine the source of superoxide overproduction during H/R we studied CA obtained from transgenic (Tg) mice overexpressing human CuZn-superoxide dismutase (SOD) and mice lacking gp91(phox) using an in vitro vascular ring bioassay. We found that under normoxic conditions CA isolated from wild type (wt) mice, CuZn-SOD Tg mice and gp91(phox) knock-out mice had similar contractile responses to U46619 and hypoxia and similar dilation responses to acetylcholine. In wt CA, 30 min of hypoxia (1% O(2)) followed by reoxygenation (16% O(2)) resulted in further coronary vasoconstriction (internal diameter from 105 +/- 11 to 84.5 +/- 17.9 microm), whereas this response was completely blocked in both CuZn-SOD Tg and gp91(phox) knock-out CA (104.3 +/- 10.5 to 120.7 +/- 14 microm and 143.3 +/- 15.3 to 172.7 +/- 12.5 microm, respectively, p < 0.01). Furthermore, we show that H/R enhances the generation of superoxide radicals in wt CA (25.8 +/- 0.7 relative light units per second (RLU/s)), whereas CuZn-SOD Tg CA (12.2 +/- 0.8 RLU/s, p < 0.01) and gp91(phox) CA (12.5 +/- 0.9 RLU/s, p < 0.01) show reduced levels. These results demonstrate that H/R-induced vasoconstriction is mediated by intracellular superoxide overproduction via endothelial NADPH oxidase gp91(phox). Therefore, increasing endogenous levels of CuZn-SOD in CA may provide a novel cardioprotective strategy for maintaining coronary perfusion under conditions of H/R.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070892     DOI: 10.1074/jbc.M402920200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase.

Authors:  Mahsa Rouhanizadeh; Juliana Hwang; Roza E Clempus; Laura Marcu; Bernard Lassègue; Alex Sevanian; Tzung K Hsiai
Journal:  Free Radic Biol Med       Date:  2005-08-10       Impact factor: 7.376

Review 2.  Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Authors:  Tohru Fukai; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

3.  Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury.

Authors:  Qiang Li; Yulong Zhang; Jennifer J Marden; Botond Banfi; John F Engelhardt
Journal:  Biochem J       Date:  2008-05-01       Impact factor: 3.857

Review 4.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

5.  Elevated Levels of Plasma Superoxide Dismutases 1 and 2 in Patients with Coronary Artery Disease.

Authors:  Ji-Ren Peng; Ting-Ting Lu; Hao-Teng Chang; Xuan Ge; Bian Huang; Wei-Min Li
Journal:  Biomed Res Int       Date:  2016-10-17       Impact factor: 3.411

6.  Promoting vascular healing using nanofibrous ticagrelor-eluting stents.

Authors:  Cheng-Hung Lee; Ming-Jer Hsieh; Kuo-Sheng Liu; Che-Wei Cheng; Shang-Hung Chang; Shih-Jung Liu; Chao-Jan Wang; Ming-Yi Hsu; Kuo-Chun Hung; Yung-Hsin Yeh; Wei-Jan Chen; I-Chang Hsieh; Jyuhn-Huarng Juang; Ming-Shien Wen
Journal:  Int J Nanomedicine       Date:  2018-10-05

7.  Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents.

Authors:  Makoto Sasaki; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

8.  Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and Obesity.

Authors:  Yves Gramlich; Andreas Daiber; Katja Buschmann; Matthias Oelze; Christian-Friedrich Vahl; Thomas Münzel; Ulrich Hink
Journal:  Oxid Med Cell Longev       Date:  2018-12-17       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.